From Ingredients to Labels: Canada’s Stricter Rules vs. U.S. Flexibility

Manufacturers are able to disguise approximately 3,000 fragrance ingredients under the term “parfum”, hiding potentially harmful ingredients and adding another barrier for consumers to have full ingredient disclosure. Does this only pertain to the American skincare and cosmetic market? While Health Canada and the U.S. Food and Drug Administration (FDA) both aim to ensure product safety, their approaches and regulations differ significantly.

As someone who has navigated the Canadian product development landscape for cosmetics and skincare, I’ve gained insight into these key differences. If you’re an avid ingredient scanner who does your research, you might be curious about how these regulations impact you as a consumer.

Ingredient Approval:

  • Canada: Cosmetic notifications must be submitted within 10 days of the product entering the market. Health Canada maintains a list of banned and restricted ingredients, leading to stricter regulations on certain substances. Ingredients deemed unsafe in Canada may still be allowed in the U.S.

  • U.S.: The FDA has fewer restrictions and does not pre-approve cosmetics, relying on post-market monitoring instead.

    Ingredient Concentrations:

    • Canada: There are specific guidelines on maximum allowable concentrations for certain ingredients, especially those with health risks.

    • U.S.: While there are regulations, they tend to be less stringent overall regarding ingredient concentrations.

    Labeling Requirements:

    • Canada: Labels must be bilingual (English and French) and provide clear, substantiated claims.

    • U.S.: Labels must list ingredients but may include less clarity around terms like "natural" or "hypoallergenic."

    Sourcing and Raw Materials:

    • Canada: There is a greater emphasis on the sourcing of raw materials, with Health Canada scrutinizing supply chains to ensure safety.

    • U.S.: The FDA has less oversight over ingredient sourcing, leading to variability in quality.

    Post-Market Surveillance:

    • Canada: Health Canada conducts proactive post-market surveillance to identify and address risks promptly.

    • U.S.: The FDA responds to consumer reports and adverse events, but action can be slower.

Public Health Over Product

I recently participated in Health Canada's Heavy Metals Compliance Verification. This project is part of the Consumer Product Enforcement Summary Reports, which undergo various compliance testing initiatives every two years. Yes—Health Canada will physically take your product (at your cost) and initiate testing to ensure compliance. This proactive approach not only emphasizes the importance of consumer safety but also holds manufacturers accountable for the quality of their products. In contrast, the U.S. FDA primarily relies on post-market surveillance, which can lead to delays in identifying potentially harmful products.

This stringent testing framework in Canada underscores that regulations go beyond mere compliance; they prioritize public health. It urges brands to be meticulous in their ingredient sourcing and formulation practices, ultimately benefiting consumers. As the beauty industry evolves, grasping these regulatory differences is essential for promoting a more transparent, responsible, and safe marketplace for all stakeholders.

Previous
Previous

What I Learned from 50 Beauty Founders Over Dinner in NYC

Next
Next

The Dirt on Clean Beauty